Toxicology report confirms pharmaceutical poisoning in death of Giorgos Mazonakis

On October 27, 2026, the toxicology report concerning singer Giorgos Mazonakis was released, officially identifying pharmaceutical poisoning as the cause of death. The findings, first presented on the television program "Protos Kafes," highlight the presence of specific substances in the singer's blood sample.

The analysis detected a combination of propofol and midazolam, which are typically used for sedation, along with flumazenil, a substance used as an antidote when respiratory function declines. Scientific teams from the Toxicology and Forensic Laboratory of the Aristotle University of Thessaloniki are currently investigating the specific dosages and the synergistic effects of these substances combined with five additional compounds found in the system, including cocaine and aripiprazole.

Authorities are continuing their investigation into the circumstances of the incident, focusing on the quantitative analysis of these findings to determine how the substances were administered and their exact impact on the singer’s health. Further updates are expected as the laboratory completes its multi-stage examination of the toxicological data.